Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Journal of Neurovirology|August 10, 2017
Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathyLuca Prosperini, Cristina Scarpazza, Luisa Imberti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2019
Should frequent MRI monitoring be performed in natalizumab-treated MS patients? A contribution to a recent debateCristina Scarpazza, Alessio Signori, Mirco Cosottini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2017
Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MSRuggero Capra, Cinzia Cordioli, Sarah Rasia, et al.
Annals of Neurology|October 9, 2024
Relapse-Associated and Relapse-Independent Contribution to Overall Expanded Disability Status Scale Progression in Multiple Sclerosis Patients Diagnosed in Different ErasNoemi Montobbio, Cinzia Cordioli, Alessio Signori, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 9, 2019
Four cases of natalizumab-related PML: a less severe course in extended interval dosing?Cristina Scarpazza, Nicola De Rossi, Giulietta Tabiadon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 28, 2022
Multiple Sclerosis Progressive Courses: A Clinical Cohort Long-Term Disability Progression StudyPaolo A Cortesi, Carla Fornari, Ruggero Capra, et al.
International Journal of Molecular Sciences|November 11, 2022
Changes in Brain Volumes Are Relevant during Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: Lessons from a Case ReportRoberto De Masi, Stefania Orlando, Silvia Armenise, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2018
Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolutionCristina Scarpazza, Alessio Signori, Luca Prosperini, et al.
Scientific Reports|November 14, 2019
Lack of specific T- and B-cell clonal expansions in multiple sclerosis patients with progressive multifocal leukoencephalopathyDiego Bertoli, Alessandra Sottini, Ruggero Capra, et al.
Plos One|December 21, 2016
Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent RegistryLuca Prosperini, Nicola de Rossi, Cristina Scarpazza, et al.
Pageof 9